Christoph Hiemke

Christoph Hiemke

Johannes Gutenberg-Universität Mainz

H-index: 68

Europe-Germany

About Christoph Hiemke

Christoph Hiemke, With an exceptional h-index of 68 and a recent h-index of 32 (since 2020), a distinguished researcher at Johannes Gutenberg-Universität Mainz, specializes in the field of Psychopharmacology, Therapeutic Drug Monitoring.

His recent articles reflect a diverse array of research interests and contributions to the field:

Pharmacokinetic correlates of clinical response in a naturalistic sample of escitalopram-treated patients

Therapeutic drug monitoring in Parkinson’s disease

Systematic review on blood concentrations of ADHD medications in children and adolescents

Update on dose-related reference ranges for psychotropic drugs

Venlafaxine’s therapeutic reference range in the treatment of depression revised: a systematic review and meta-analysis

Assessing pharmacokinetic correlates of escitalopram-related adverse drug reactions

Personalized switching from oral to long-acting injectable second-generation antipsychotics in schizophrenia treatment using pharmacokinetic considerations

Therapeutic Reference Range for

Christoph Hiemke Information

University

Position

University Medical Center Mainz

Citations(all)

21378

Citations(since 2020)

6443

Cited By

17295

hIndex(all)

68

hIndex(since 2020)

32

i10Index(all)

334

i10Index(since 2020)

144

Email

University Profile Page

Johannes Gutenberg-Universität Mainz

Google Scholar

View Google Scholar Profile

Christoph Hiemke Skills & Research Interests

Psychopharmacology

Therapeutic Drug Monitoring

Top articles of Christoph Hiemke

Title

Journal

Author(s)

Publication Date

Pharmacokinetic correlates of clinical response in a naturalistic sample of escitalopram-treated patients

Nicholas Kasperk

Ekkehard Haen

Christoph Hiemke

Thomas Frodl

Georgios Schoretsanitis

...

2024/3/3

Therapeutic drug monitoring in Parkinson’s disease

Pharmacopsychiatry

T Müller

M Gerlach

G Hefner

W Jost

C Hiemke

...

2024/3

Systematic review on blood concentrations of ADHD medications in children and adolescents

SS Hagenkötter

K Egberts

S Fekete

M Gerlach

C Hiemke

...

2024/3

Update on dose-related reference ranges for psychotropic drugs

Pharmacopsychiatry

FJ Amann

K Endres

C Hiemke

G Zernig

G Gründer

...

2024/3

Venlafaxine’s therapeutic reference range in the treatment of depression revised: a systematic review and meta-analysis

XM Lense

C Hiemke

CSM Funk

U Havemann-Reinecke

G Hefner

...

2024/2

Assessing pharmacokinetic correlates of escitalopram-related adverse drug reactions

Therapeutic Drug Monitoring

Maxim Kuzin

Ekkehard Haen

Nazar Kuzo

Katharina Endres

Christoph Hiemke

...

2024/4/1

Personalized switching from oral to long-acting injectable second-generation antipsychotics in schizophrenia treatment using pharmacokinetic considerations

Georgios Schoretsanitis

Jonathan M Meyer

Andreas Conca

Christoph Hiemke

2023/4/3

Therapeutic Reference Range for

JOURNAL OF CLINICAL PSYCHIATRY

Katja Wesner

Christoph Hiemke

Niels Bergemann

Karin M Egberts

Stefanie Fekete

...

2023/9/1

Lower sertraline plasma concentration in patients co‐medicated with clozapine—Implications for pharmacological augmentation strategies in schizophrenia

Pharmacology Research & Perspectives

Arnim Johannes Gaebler

Ekkehard Haen

Nagia Ben Omar

Katharina Endres

Christoph Hiemke

...

2023/4

An international adult guideline for making clozapine titration safer by using six ancestry-based personalized dosing titrations, CRP, and clozapine levels

Psiquiatria Biologica

Jose de Leon

Georgios Schoretsanitis

Robert L Smith

Espen Molden

Anssi Solismaa

...

2023/9/1

Concentrations of escitalopram in blood of patients treated in a naturalistic setting: focus on patients with alcohol and benzodiazepine use disorder

European Archives of Psychiatry and Clinical Neuroscience

XM Hart

S Heesen

CN Schmitz

S Dörfler

D Wedekind

...

2023/2

Guía internacional para una dosificación más segura de la clozapina en adultos mediante el uso de 6 titulaciones personalizadas de dosis basados en la etnicidad, la proteína C …

Psiquiatría Biológica

Jose de Leon

Georgios Schoretsanitis

Robert L Smith

Espen Molden

Anssi Solismaa

...

2023/9/1

Decreased concentrations of quetiapine in plasma of patients under co-medication with metamizole

Fabian Watermeyer

Arnim Johannes Gaebler

Irene Neuner

Ekkehard Haen

Christoph Hiemke

...

2023/1/3

Therapeutic reference range for olanzapine in schizophrenia: Systematic review on blood concentrations, clinical effects, and dopamine receptor occupancy

Katja Wesner

Christoph Hiemke

Niels Bergemann

Karin M Egberts

Stefanie Fekete

...

2023/7/19

LIST OF SUPPLEMENTARY MATERIAL FOR THE ARTICLE

Chirag M Vyas

David Mischoulon

Grace Chang

Nancy R Cook

Alison Weinberg

...

2023

Discovering Interactions in polypharmacy: Impact of Metamizole on the Metabolism of Quetiapine

Authorea Preprints

Fabian Watermeyer

Arnim Johannes Gaebler

Irene Neuner

Ekkehard Haen

Christoph Hiemke

...

2023/6/13

Pharmakokinetik und Arzneimittelinteraktionen

Christoph Hiemke

Gudrun Hefner

Otto Benkert

2023/10/26

Levomethadone Therapeutic Drug Monitoring to Aid Opioid Withdrawal Therapy: A Short Communication

Therapeutic Drug Monitoring

Philippe Pfeifer

Kathrin Hildebrand

Andreas Angelov

Ursula Havemann-Reinecke

Michael Böttcher

...

2022/4/4

Therapeutic reference range for aripiprazole revised: a systematic review and combined analysis

XM Hart

Christoph Hiemke

Hans-Willi Clement

Andreas Conca

Luzie Eichentopf

...

2022/5

Pharmacokinetic and pharmacodynamic principles

Gerald Zernig

Christoph Hiemke

2022/11/5

See List of Professors in Christoph Hiemke University(Johannes Gutenberg-Universität Mainz)